PANEL DISCUSSION – The Road Ahead: Topicals vs Orals vs Alternative Delivery Methods

Time: 9:30 am
day: Day One


  • Exploring the JAK inhibitor drug development landscape and weighing the merit of pursuing topical vs oral vs
    alternative application
  • Considering the cost concerns and systemic effects associated with oral and injectable delivery systems whilst
    discussing the small potential for off-target effects in topical creams
  • Discussing the need to equate disease severity and quality of life with safety concerns associated with JAK inhibition
  • Reflecting on the practicality of topical delivery as a long-term disease management strategy